My moment of sarcasm was only at the idea that they had pre-named it.
Which is not at all unusual in studies.
If it had been stated as a term to use instead, it would have slipped by the sarcasm mode of my brain.
It took me a couple times reading it to grasp the complete idea and concept they were stating.
Not a big deal, I have written many proposal's in the past that my superiors handed back.
Asking me to rewrite it in a way they and others could better understand it.
"Less street slang", was a common response.
Usually the biggest part of the battle to get funding and the go ahead to start.
The name fits, I hope it pans out into bigger and better studies, as always.
Hormonal cascading is of a great interest to me, I'm glad that it is a component of the study and research.
Hormone levels flucuate, nothing new there, to approach them as a cascade effect goes with what I have thought for a long time.
It should prove interesting. Again, I hope that pans out into more research.
Along with the rest of it, of course. It's very interesting, a novel approach instead of rehashing old ideas.
AGI, Alternating Gender Incongruity, is a proper designation. It's not weird, it's descriptive.
I just hope the psychiatric and pharmaceutical people don't look at it as an opportunity to make it a disorder.
Thereby using it as something that needs massively wrong medications, for massive profits.
It's still Bigender to me, a gender unique in it's own qualities.
Non-binary by my definition...
Ativan
